4.8 Article

Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins

期刊

NATURE BIOTECHNOLOGY
卷 31, 期 12, 页码 1137-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.2726

关键词

-

资金

  1. National Institutes of Health (NIH) [DP1 GM105378, P50 HG005550, R01 HD053808, R01 HD045595, R01 CA169316, F32 GM105189, P30 NS45776]
  2. Defense Advanced Research Projects Agency (DARPA) [W911NF-11-2-0056]
  3. Karen Osney Brownstein Endowed Chair
  4. Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award
  5. US National Science Foundation Graduate Research Fellowship

向作者/读者索取更多资源

Genome-wide studies have defined cell type-specific patterns of DNA methylation(1) that are important for regulating gene expression in both normal development(2) and disease(3). However, determining the functional significance of specific methylation events remains challenging, owing to the lack of methods for removing such modifications in a targeted manner. Here we describe an approach for efficient targeted demethylation of specific CpGs in human cells using fusions of engineered transcription activator-like effector (TALE) repeat arrays and the TET1 hydroxylase catalytic domain. Using these TALE-TET1 fusions, we demonstrate that modification of critical methylated promoter CpG positions can lead to substantial increases in the expression of endogenous human genes. Our results delineate a strategy for understanding the functional significance of specific CpG methylation marks in the context of endogenous gene loci and validate programmable DNA demethylation reagents with potential utility for research and therapeutic applications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据